Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rheumatology | 6 | 2023 | 130 | 1.580 |
Why?
|
| Arthritis, Juvenile | 4 | 2023 | 45 | 1.490 |
Why?
|
| Lupus Erythematosus, Systemic | 7 | 2025 | 229 | 1.170 |
Why?
|
| Teratogens | 1 | 2023 | 68 | 0.740 |
Why?
|
| Pregnancy in Adolescence | 1 | 2023 | 54 | 0.730 |
Why?
|
| Lupus Nephritis | 3 | 2022 | 43 | 0.560 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 4 | 2025 | 78 | 0.510 |
Why?
|
| Biomedical Research | 1 | 2022 | 561 | 0.460 |
Why?
|
| Immunosuppressive Agents | 6 | 2022 | 663 | 0.380 |
Why?
|
| Pediatrics | 1 | 2022 | 1252 | 0.360 |
Why?
|
| Glucocorticoids | 1 | 2022 | 348 | 0.300 |
Why?
|
| Immunoglobulins, Intravenous | 4 | 2022 | 148 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 981 | 0.240 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 639 | 0.230 |
Why?
|
| Hodgkin Disease | 1 | 2008 | 307 | 0.230 |
Why?
|
| Vasculitis | 1 | 2025 | 47 | 0.220 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 786 | 0.220 |
Why?
|
| Lymphedema | 1 | 2004 | 18 | 0.220 |
Why?
|
| Mycophenolic Acid | 2 | 2017 | 54 | 0.210 |
Why?
|
| Frameshift Mutation | 1 | 2004 | 200 | 0.200 |
Why?
|
| Economics, Behavioral | 1 | 2023 | 9 | 0.190 |
Why?
|
| Social Determinants of Health | 1 | 2025 | 165 | 0.190 |
Why?
|
| Contraception | 1 | 2023 | 61 | 0.180 |
Why?
|
| Antirheumatic Agents | 1 | 2023 | 123 | 0.170 |
Why?
|
| Histoplasmosis | 1 | 2021 | 55 | 0.160 |
Why?
|
| Child | 14 | 2025 | 26341 | 0.160 |
Why?
|
| Stomatitis, Aphthous | 1 | 2020 | 3 | 0.160 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 334 | 0.160 |
Why?
|
| Rheumatic Diseases | 1 | 2021 | 78 | 0.160 |
Why?
|
| Kidney Diseases | 1 | 2004 | 477 | 0.160 |
Why?
|
| Pharyngitis | 1 | 2020 | 34 | 0.160 |
Why?
|
| Health Equity | 1 | 2022 | 78 | 0.160 |
Why?
|
| Lymphadenitis | 1 | 2020 | 25 | 0.160 |
Why?
|
| Humans | 22 | 2025 | 131163 | 0.150 |
Why?
|
| Quality Improvement | 2 | 2023 | 722 | 0.150 |
Why?
|
| Pneumococcal Vaccines | 1 | 2020 | 174 | 0.140 |
Why?
|
| Age of Onset | 3 | 2022 | 592 | 0.130 |
Why?
|
| Adolescent | 7 | 2025 | 20987 | 0.130 |
Why?
|
| Fever | 1 | 2020 | 312 | 0.130 |
Why?
|
| Pneumococcal Infections | 1 | 2020 | 281 | 0.130 |
Why?
|
| Documentation | 1 | 2018 | 121 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 889 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1939 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2004 | 2406 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2020 | 844 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2020 | 333 | 0.100 |
Why?
|
| Vaccination | 1 | 2020 | 1060 | 0.100 |
Why?
|
| Algorithms | 1 | 2020 | 1680 | 0.090 |
Why?
|
| Female | 9 | 2025 | 70963 | 0.090 |
Why?
|
| Psychotic Disorders | 1 | 2013 | 146 | 0.090 |
Why?
|
| Remission Induction | 1 | 2012 | 306 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 789 | 0.080 |
Why?
|
| Hydroxychloroquine | 1 | 2011 | 21 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 60 | 0.080 |
Why?
|
| Oligonucleotides | 1 | 2011 | 94 | 0.080 |
Why?
|
| Virus Diseases | 1 | 2013 | 285 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2013 | 327 | 0.080 |
Why?
|
| Pregnancy | 1 | 2023 | 7512 | 0.080 |
Why?
|
| Rituximab | 1 | 2011 | 170 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2022 | 297 | 0.080 |
Why?
|
| Patient Participation | 1 | 2022 | 254 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2011 | 428 | 0.070 |
Why?
|
| Sialyltransferases | 1 | 2008 | 7 | 0.070 |
Why?
|
| Etanercept | 1 | 2008 | 44 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 73 | 0.070 |
Why?
|
| Infliximab | 1 | 2008 | 61 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2022 | 645 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 570 | 0.060 |
Why?
|
| Male | 8 | 2025 | 64957 | 0.060 |
Why?
|
| Health Services Accessibility | 2 | 2025 | 712 | 0.060 |
Why?
|
| Takayasu Arteritis | 1 | 2025 | 13 | 0.060 |
Why?
|
| Polyarteritis Nodosa | 1 | 2025 | 11 | 0.060 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2025 | 27 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2004 | 58 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2008 | 395 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17753 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 744 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 599 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2025 | 263 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2021 | 15110 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2004 | 371 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 3061 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 776 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2008 | 1559 | 0.040 |
Why?
|
| Retreatment | 1 | 2021 | 85 | 0.040 |
Why?
|
| Young Adult | 3 | 2024 | 10103 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 1207 | 0.040 |
Why?
|
| Pedigree | 1 | 2004 | 1677 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2023 | 240 | 0.040 |
Why?
|
| Base Sequence | 1 | 2004 | 2730 | 0.040 |
Why?
|
| Cimetidine | 1 | 2020 | 16 | 0.040 |
Why?
|
| Tubulin Modulators | 1 | 2020 | 11 | 0.040 |
Why?
|
| Antipyretics | 1 | 2020 | 7 | 0.040 |
Why?
|
| Colchicine | 1 | 2020 | 40 | 0.040 |
Why?
|
| Nursing Staff | 1 | 2020 | 12 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 39 | 0.040 |
Why?
|
| Histamine H2 Antagonists | 1 | 2020 | 59 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 2020 | 80 | 0.040 |
Why?
|
| DNA | 1 | 2004 | 1399 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2020 | 150 | 0.040 |
Why?
|
| Neck | 1 | 2020 | 140 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 104 | 0.040 |
Why?
|
| Infant | 2 | 2018 | 13352 | 0.030 |
Why?
|
| Tonsillectomy | 1 | 2020 | 114 | 0.030 |
Why?
|
| Rheumatologists | 1 | 2017 | 7 | 0.030 |
Why?
|
| Research Design | 1 | 2022 | 716 | 0.030 |
Why?
|
| Nephrologists | 1 | 2017 | 19 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 1155 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 3436 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 276 | 0.030 |
Why?
|
| Pediatricians | 1 | 2017 | 78 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 523 | 0.030 |
Why?
|
| Texas | 1 | 2025 | 3686 | 0.030 |
Why?
|
| Biomarkers | 1 | 2025 | 3385 | 0.030 |
Why?
|
| United States | 2 | 2022 | 12072 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 262 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2020 | 562 | 0.030 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 279 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 2825 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1295 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1882 | 0.020 |
Why?
|
| Echocardiography | 1 | 2018 | 1125 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1483 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 4497 | 0.020 |
Why?
|
| Australia | 1 | 2008 | 173 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2008 | 316 | 0.020 |
Why?
|
| Kidney | 1 | 2013 | 1282 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12936 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 2833 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 31282 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 11074 | 0.010 |
Why?
|
YILDIRIM TORUNER's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_